Federal award (BPA CALL, fiscal year 2022)
Recipient: BRILLIENT CORPORATION
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2019-08-16 to 2020-11-15
Current total value of award: $219423.52
Description: TO ACQUIRE POLICY ANALYST SERVICES TO CONDUCT REGULATORY AND HISTORICAL RESEARCH AND ANALYSIS TO LABEL THE REFERENCE LISTED DRUG (RLD) FOR ANDAS IN THE GENERIC DRUG REVIEW PLATFORM.  THE POLICY ANALYST SHALL DOCUMENT, TRACK, AND PROVIDE RLD INFORMATI